Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review
Nutrients · 05.04.2026 · 18 (7) · 1161
DOI: 10.3390/nu18071161 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 05.04.2026. Verfasst von Hui San Chin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Office, Sengkang General Hospital, Singapore 544886, Singapore. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SingHealth Duke-NUS Academic Medicine Research Grant, Sengkang General Hospital Centre Grant Seed, Sengkang General Hospital Center Grant Seed.
Abstract (Originalsprache)
Sarcopenia is a progressive and multifactorial muscle disorder associated with diminished strength, reduced functional capacity, and increased risk of adverse health outcomes including frailty, falls, and mortality. Despite its clinical burden, the molecular pathogenesis of sarcopenia remains poorly understood, which hinders the development of precise therapeutic strategies. This review examines emerging evidence linking anabolic resistance, mitochondrial dysfunction, neuromuscular instability, and chronic inflammation to impaired regeneration and disrupted proteostasis. While nutritional interventions such as high-quality protein, leucine metabolites, and vitamin D supplementation preserve lean mass, they fail to consistently restore function independently. Although exercise remains the cornerstone therapy, its benefits are often constrained in patients with multimorbidity or reduced mobility. Given the biological heterogeneity of sarcopenia, there is a need to shift from generic supportive care to stratified, mechanism-based therapy. Emerging omics technologies including transcriptomic, proteomic, and metabolic profiling offer a promising avenue to define molecular endotypes. This will guide the development of precision-based management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Office, Sengkang General Hospital, Singapore 544886, Singapore.
- SingHealth Duke-NUS Muscle Health Program, SingHealth, Singapore 168582, Singapore.
- Surgery Academic Clinical Programme, Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore.
- Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore 138672, Singapore.
- Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Center Singapore, Singapore 168583, Singapore.
- Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore.
ORCID-Profile: Ling Liu, Pei-Ju Liao, Frederick H Koh
Förderung
- SingHealth Duke-NUS Academic Medicine Research Grant
- Sengkang General Hospital Centre Grant Seed
- Sengkang General Hospital Center Grant Seed
Zitieren
APA
Chin, H. S., Liu, L., Liao, P. J., Wee, A. L. R. M., Kwek, X. Y., Teh, B. T., & Koh, F. H. (2026). Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review. Nutrients, 18(7), 1161. https://doi.org/10.3390/nu18071161
Vancouver
Chin HS, Liu L, Liao PJ, Wee ALRM, Kwek XY, Teh BT, et al. Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review. Nutrients. 2026;18(7):1161. doi:10.3390/nu18071161
BibTeX
@article{Chin2026,
author = {Chin, Hui San and Liu, Ling and Liao, Pei-Ju and Wee, Alexandra L R M and Kwek, Xiu-Yi and Teh, Bin Tean and Koh, Frederick H},
title = {Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {7},
pages = {1161},
doi = {10.3390/nu18071161}
}
EUVIMED